[go: up one dir, main page]

PE35896A1 - Heteroaril-oxazolidinona de 5 eslabones - Google Patents

Heteroaril-oxazolidinona de 5 eslabones

Info

Publication number
PE35896A1
PE35896A1 PE1995274242A PE27424295A PE35896A1 PE 35896 A1 PE35896 A1 PE 35896A1 PE 1995274242 A PE1995274242 A PE 1995274242A PE 27424295 A PE27424295 A PE 27424295A PE 35896 A1 PE35896 A1 PE 35896A1
Authority
PE
Peru
Prior art keywords
carbon
preference
formula
group
atoms
Prior art date
Application number
PE1995274242A
Other languages
English (en)
Inventor
Dieter Habich
Andreas Stolle
Hanno Wild
Hein-Peter Kroll
Klaus Dieter Bremm
Klaus Schaller
Hans-Otto Werling
Rainer Endermann
Bernd Riedl
Harald Labischinski
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of PE35896A1 publication Critical patent/PE35896A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/48—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/08—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing alicyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

SE REFIERE AL COMPUESTO DE FORMULA I DONDE: R1 REPRESENTA AZIDO, HIDROXILO o UN GRUPO DE FORMULA -OR2, -OSO2R3 o -NR4R5, DONDE R2 ES ACILO, LINEAL o RAMIFICADO, CON HASTA OCHO ATOMOS DE CARBONO, DE PREFERENCIA SEIS; R3 ES ALQUILO LINEAL O RAMIFICADO, CON HASTA CUATRO ATOMOS DE CARBONO, DE PREFERENCIA TRES, PUDIENDO SER METILO, ETILO, FENILO O TOLILO; R4 Y R5 SON IGUALES O DISTINTOS Y SIGNIFICAN CICLOALQUILO CON TRES A SEIS ATOMOS DE CARBONO, DE PREFERENCIA CICLOPROPILO O CICLOPENTILO, o R4 Y R5 SIGNIFICA UN GRUPO DE FORMULA -CO-R6 DONDE R6 ES CICLOALQUILO CON TRES A SEIS ATOMOS DE CARBONO, DE PREFERENCIA CICLOPROPILO, CICLOBUTILO, ENTRE OTROS; A REPRESENTA UN HETEROCICLO AROMATICO DE CINCO ESLABONES UNIDO DIRECTAMENTE SOBRE UN ATOMO DE CARBONO, CON HASTA TRES HETEROATOMOS DEL GRUPO S, N y/u O, QUE ADICIONALMENTE PUEDE POSEER UN ANILLO DE BENCENO O NAFTALENO CONDENSADO, DONDE LOS CICLOS PUEDEN ESTAR HASTA TRISUSTITUIDO POR SUSTITUYENTES IGUALES O DISTINTINTOS TALES COMO CARBOXI, HALOGENO, CIANO, MERCAPTO, FORMILO, ENTRE OTROS, PUDIENDO DE PREFERENCIA SER PIRROLILO, IMIDAZOLILO, FURILO, ENTRE OTROS. ESTOS MEDICAMENTOS SE CARACTERIZAN POR SER ANTIBACTERIANOS
PE1995274242A 1994-07-20 1995-07-19 Heteroaril-oxazolidinona de 5 eslabones PE35896A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4425613A DE4425613A1 (de) 1994-07-20 1994-07-20 5-gliedrige Heteroaryl-oxazolidinone

Publications (1)

Publication Number Publication Date
PE35896A1 true PE35896A1 (es) 1996-10-14

Family

ID=6523633

Family Applications (1)

Application Number Title Priority Date Filing Date
PE1995274242A PE35896A1 (es) 1994-07-20 1995-07-19 Heteroaril-oxazolidinona de 5 eslabones

Country Status (28)

Country Link
US (1) US5698574A (es)
EP (1) EP0693491A1 (es)
JP (1) JPH0853443A (es)
KR (1) KR960004343A (es)
CN (1) CN1121919A (es)
AU (1) AU695661B2 (es)
BG (1) BG99791A (es)
CA (1) CA2154026A1 (es)
CO (1) CO4410193A1 (es)
CZ (1) CZ187395A3 (es)
DE (1) DE4425613A1 (es)
EE (1) EE9500044A (es)
FI (1) FI953476A (es)
HR (1) HRP950391A2 (es)
HU (1) HUT74003A (es)
IL (1) IL114622A (es)
MA (1) MA23621A1 (es)
NO (1) NO304488B1 (es)
NZ (1) NZ272596A (es)
PE (1) PE35896A1 (es)
PL (1) PL309685A1 (es)
RO (1) RO115161B1 (es)
RU (1) RU95113086A (es)
SK (1) SK91695A3 (es)
SV (1) SV1995000042A (es)
TN (1) TNSN95083A1 (es)
YU (1) YU49195A (es)
ZA (1) ZA956015B (es)

Families Citing this family (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4425609A1 (de) * 1994-07-20 1996-01-25 Bayer Ag Benzofuranyl- und Benzothienyloxazolidinone
RU2154645C2 (ru) * 1995-02-03 2000-08-20 Фармация Энд Апджон Компани Фенилоксазолидиноны, замещенные в кольце гетероароматическими кольцами, в качестве антимикробных агентов
US6124334A (en) * 1995-02-03 2000-09-26 Pharmacia & Upjohn Company Hetero-aromatic ring substituted phenyloxazolidinone antimicrobials
NZ315469A (en) * 1995-09-01 2000-01-28 Upjohn Co Phenyloxazolidinones having a c-c bond to 4-8 membered heterocyclic rings
DE19601264A1 (de) * 1996-01-16 1997-07-17 Bayer Ag Pyrido-annellierte Thienyl- und Furanyl-Oxazolidinone
GB9601666D0 (en) * 1996-01-27 1996-03-27 Zeneca Ltd Chemical compounds
DE19604223A1 (de) * 1996-02-06 1997-08-07 Bayer Ag Neue substituierte Oxazolidinone
HRP970049A2 (en) * 1996-02-06 1998-04-30 Bayer Ag New heteroaryl oxazolidinones
GB9702213D0 (en) * 1996-02-24 1997-03-26 Zeneca Ltd Chemical compounds
GB9609919D0 (en) 1996-05-11 1996-07-17 Zeneca Ltd Chemical compounds
DK0920421T3 (da) * 1996-08-21 2003-03-10 Upjohn Co Isoxazolinderivater anvendelige som antimikrobielle midler
GB9717807D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9717804D0 (en) 1997-08-22 1997-10-29 Zeneca Ltd Chemical compounds
GB9725244D0 (en) 1997-11-29 1998-01-28 Zeneca Ltd Chemical compounds
NZ505902A (en) 1998-01-23 2003-08-29 Upjohn Co Oxazolidinone compounds useful as antimicrobial agents and combinatorial libraries
US7002020B1 (en) 1998-01-23 2006-02-21 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6562844B2 (en) 1998-01-23 2003-05-13 Pharmacia & Upjohn Company Oxazolidinone combinatorial libraries, compositions and methods of preparation
US6262044B1 (en) * 1998-03-12 2001-07-17 Novo Nordisk A/S Modulators of protein tyrosine phosphatases (PTPASES)
US6221902B1 (en) 1998-05-12 2001-04-24 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
CA2331056A1 (en) 1998-05-12 1999-12-02 Wyeth 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
US6251936B1 (en) 1998-05-12 2001-06-26 American Home Products Corporation Benzothiophenes, benzofurans, and indoles useful in the treatment of insulin resistance and hyperglycemia
US6121271A (en) * 1998-05-12 2000-09-19 American Home Products Corporation Naphtho[2,3-B]heteroar-4-yl derivatives
US6699896B1 (en) 1998-05-12 2004-03-02 Wyeth Oxazole-aryl-carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
EE200000653A (et) * 1998-05-12 2002-04-15 American Home Products Corporation Bensotiofeenid, bensofuraanid ja indoolid kasutamiseks insuliiniresistentsuse ning hüperglükeemia ravis
US6110962A (en) * 1998-05-12 2000-08-29 American Home Products Corporation 11-aryl-benzo[B]naphtho[2,3-D]furans and 11-aryl-benzo[B]naphtho[2,3-D]thiophenes useful in the treatment of insulin resistance and hyperglycemia
US6451827B2 (en) 1998-05-12 2002-09-17 Wyeth 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
US6110963A (en) * 1998-05-12 2000-08-29 American Home Products Corporation Aryl-oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
US6232322B1 (en) 1998-05-12 2001-05-15 American Home Products Corporation Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
MY122454A (en) * 1998-06-05 2006-04-29 Upjohn Co Use of oxazolidinones for the preparation of a medicament for transdermal delivery
HUP0103082A3 (en) * 1998-06-05 2002-12-28 Astrazeneca Ab Oxazolidinone derivatives, process for their preparation and pharmaceutical compositions containing them
EE200100026A (et) * 1998-07-14 2002-06-17 Pharmacia & Upjohn Company Oksasolidinoonid silmahaiguste raviks
US6420349B1 (en) 1998-08-24 2002-07-16 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
AR020660A1 (es) * 1998-09-30 2002-05-22 Alcon Lab Inc Composiciones antibioticas para el tratamiento de ojos, oidos y nariz
JP2002535680A (ja) 1999-01-27 2002-10-22 ファルマシア・アンド・アップジョン・カンパニー 延長因子ｐ活性モジュレーターのアッセイ方法
US6310081B1 (en) 1999-05-10 2001-10-30 American Home Products Corporation Biphenyl sulfonyl aryl carboxylic acids useful in the treatment of insulin resistance and hyperglycemia
GB9928568D0 (en) 1999-12-03 2000-02-02 Zeneca Ltd Chemical compounds
US6514529B2 (en) 2000-03-22 2003-02-04 Pharmacia & Upjohn Company Oxazolidinone tablet formulation
MY127336A (en) 2000-03-22 2006-11-30 Upjohn Co Container for linezolid iv solution
GB0009803D0 (en) * 2000-04-25 2000-06-07 Astrazeneca Ab Chemical compounds
US6465456B2 (en) 2000-06-29 2002-10-15 Bristol-Myers Squibb Company Isoxazolinone antibacterial agents
WO2002002095A2 (en) 2000-06-30 2002-01-10 Pharmacia & Upjohn Company Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin
PE20020300A1 (es) * 2000-08-22 2002-05-10 Pharmacia Corp Composicion de solucion de un farmaco antibiotico a base de oxazolidinona con mejoramiento de la carga de farmaco
WO2002018354A1 (en) * 2000-08-31 2002-03-07 Abbott Laboratories Oxazolidinones and their use as antibacterial agents
AR031135A1 (es) 2000-10-10 2003-09-10 Upjohn Co Composiciones de antibiotico topico para el tratamiento de infecciones oculares
WO2002059116A2 (en) 2000-12-21 2002-08-01 Pharmacia & Upjohn Company Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
GB0118407D0 (en) * 2001-07-27 2001-09-19 Cipla Ltd Oxazolidinone derivatives as antibacterial agents
JP2003192773A (ja) * 2001-12-26 2003-07-09 Mitsui Chemicals Inc 生体吸収性ポリヒドロキシカルボン酸及びその製造法
TW200302095A (en) * 2002-01-25 2003-08-01 Upjohn Co Oxazolidinone cotherapy
AU2003218059A1 (en) * 2002-02-22 2003-09-09 Pharmacia Corporation Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
AR038536A1 (es) * 2002-02-25 2005-01-19 Upjohn Co N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
US7141588B2 (en) * 2002-02-25 2006-11-28 Pfizer, Inc. N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
WO2003084534A1 (en) * 2002-03-29 2003-10-16 Pharmacia & Upjohn Company Llc Parenteral, intravenous, and oral administration of oxazolidinones for treating diabetic foot infections
CA2491287A1 (en) * 2002-08-12 2004-02-19 Pharmacia & Upjohn Company N-aryl-2-oxazolidinones and their derivatives
EP1565186B1 (en) * 2002-11-21 2006-11-02 Pharmacia & Upjohn Company LLC N-(4-(piperazin-1-yl)-phenyl-2-oxazolidinone-5-carboxamide derivates and related compounds as antibacterial agents
MXPA05005651A (es) * 2002-11-28 2005-07-27 Astrazeneca Ab Derivados de oxazolidinona y/o isoxazolina como agentes antibacterianos.
GB0229526D0 (en) * 2002-12-19 2003-01-22 Astrazeneca Ab Chemical compounds
US20040170686A1 (en) * 2003-01-31 2004-09-02 Fredrickson Jennifer K. Suspension vehicle for coated drug particles
WO2004069832A2 (en) * 2003-02-07 2004-08-19 Warner-Lambert Company Llc Antibacterial agents
EP1594494A1 (en) * 2003-02-07 2005-11-16 Warner-Lambert Company LLC Oxazolidinone derivatives n-substituted by a bicyclic ring, for use as antibacterial agents
US20040191326A1 (en) * 2003-03-31 2004-09-30 Reo Joseph P. Taste-masking vehicle for coated oxazolidinone particles
US20040204463A1 (en) * 2003-04-01 2004-10-14 Harris Christina Renee N-aryl-2-oxazolidinone-5-carboxamides and their derivatives
CA2536480A1 (en) * 2003-08-25 2005-03-03 Warner-Lambert Company Llc Novel antimicrobial aryloxazolidinone compounds
US7304050B2 (en) * 2003-09-16 2007-12-04 Pfizer Inc. Antibacterial agents
AU2006231919A1 (en) 2005-04-06 2006-10-12 Pharmacia & Upjohn Company Llc 7-fluoro-1,3-dihydro-indol-2-one oxazolidinones as antibacterial agents
WO2008021338A2 (en) * 2006-08-15 2008-02-21 Wyeth Tricyclic oxazolidone derivatives useful as pr modulators
TW200815428A (en) * 2006-08-15 2008-04-01 Wyeth Corp Oxazolidone derivatives as PR modulators
US7538107B2 (en) * 2006-08-15 2009-05-26 Wyeth Oxazinan-2-one derivatives useful as PR modulators
CL2008000662A1 (es) * 2007-03-09 2008-04-25 Wyeth Corp Forma cristalina de 4-(2-(4,4-dimetil-2-oxooxazolidin-3-il) tiazo-4-il) benzonitrilo; metodo para la preparacion de dicho compuesto; composicion farmaceutica que comprende a dicho compuesto; kit farmaceutico que comprende a dicho compuesto; y su uso
WO2013182070A1 (zh) * 2012-06-08 2013-12-12 四川贝力克生物技术有限责任公司 一种用于预防或治疗分支杆菌疾病的药物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL103945C (es) * 1958-09-30
DE2304589A1 (de) * 1973-01-31 1974-08-01 Bayer Ag 3-alkyloxazolinone-(2)
JPS5735589A (en) * 1980-08-11 1982-02-26 Nippon Soda Co Ltd 5-thienyloxazoline derivative, its preparation and selective herbicide
JPS59216885A (ja) * 1983-05-20 1984-12-06 Kissei Pharmaceut Co Ltd チオフエン誘導体及びその製造方法
US4705799A (en) * 1983-06-07 1987-11-10 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl benzenes useful as antibacterial agents
JPS6183170A (ja) * 1984-09-28 1986-04-26 Nippon Chemiphar Co Ltd 新規な１，３−オキサゾリジン−２−オン誘導体およびその製造法
DE3723797A1 (de) * 1987-07-18 1989-01-26 Merck Patent Gmbh Oxazolidinone
US4921869A (en) * 1987-10-09 1990-05-01 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4965268A (en) * 1987-10-09 1990-10-23 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US4801600A (en) * 1987-10-09 1989-01-31 E. I. Du Pont De Nemours And Company Aminomethyl oxooxazolidinyl cycloalkylbenzene derivatives useful as antibacterial agents
US5036092A (en) * 1987-10-09 1991-07-30 Du Pont Merck Pharmaceutical Aminomethyl oxooxazolidinyl azacycloalkylbenzene derivatives useful as antibacterial agents
CA1320730C (en) * 1987-10-16 1993-07-27 The Du Pont Merck Pharmaceutical Company Aminomethyl oxooxazolidinyl aroylbenzene derivatives useful as antibacterial agents
US5254577A (en) * 1988-07-29 1993-10-19 The Du Pont Merck Pharmaceutical Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
US4948801A (en) * 1988-07-29 1990-08-14 E. I. Du Pont De Nemours And Company Aminomethyloxooxazolidinyl arylbenzene derivatives useful as antibacterial agents
WO1990002744A1 (en) * 1988-09-15 1990-03-22 The Upjohn Company In position 3 substituted-5-beta-amidomethyl-oxazolidin-2-ones
DE3902439A1 (de) * 1989-01-27 1990-08-02 Basf Ag Pflanzenschuetzende mittel auf basis von 1-aryl- bzw. 1-hetarylimidazolcarbonsaeureestern
EP0610265B1 (en) * 1991-11-01 1996-12-27 PHARMACIA & UPJOHN COMPANY Substituted aryl- and heteroarylphenyloxazolidinones useful as antibacterial agents

Also Published As

Publication number Publication date
MA23621A1 (fr) 1996-04-01
HUT74003A (en) 1996-10-28
FI953476A0 (fi) 1995-07-18
FI953476A (fi) 1996-01-21
AU695661B2 (en) 1998-08-20
CN1121919A (zh) 1996-05-08
TNSN95083A1 (fr) 1996-02-06
ZA956015B (en) 1996-02-22
EP0693491A1 (de) 1996-01-24
NZ272596A (en) 1997-03-24
BG99791A (en) 1996-04-30
SK91695A3 (en) 1996-02-07
US5698574A (en) 1997-12-16
JPH0853443A (ja) 1996-02-27
DE4425613A1 (de) 1996-01-25
HU9502167D0 (en) 1995-09-28
YU49195A (sh) 1998-12-23
IL114622A (en) 1999-07-14
SV1995000042A (es) 1996-03-28
NO304488B1 (no) 1998-12-28
EE9500044A (et) 1996-02-15
PL309685A1 (en) 1996-01-22
HRP950391A2 (en) 1997-06-30
AU2498895A (en) 1996-02-01
IL114622A0 (en) 1995-11-27
CO4410193A1 (es) 1997-01-09
RO115161B1 (ro) 1999-11-30
NO952866L (no) 1996-01-22
NO952866D0 (no) 1995-07-19
RU95113086A (ru) 1997-06-27
CA2154026A1 (en) 1996-01-21
KR960004343A (ko) 1996-02-23
CZ187395A3 (en) 1996-02-14

Similar Documents

Publication Publication Date Title
PE35896A1 (es) Heteroaril-oxazolidinona de 5 eslabones
CO4520187A1 (es) Tienil- y furanil-oxazolidinonas piridocondensadas
CO4410194A1 (es) Heteroaril-oxazolidinonas de 6 eslabones que contienen ni- trogeno.
AR240794A2 (es) Derivados de 2-(2'-nitrobenzoil)-1,3-ciclohexanodiona composicion herbicida que los comprende y procedimiento para prepararlos.
BR1100989A (pt) Composto e composição de matéria
FI932103A (fi) Nya 4-arylpiperaziner och 4-arylpiperidiner
DE59204623D1 (de) Lagerstabile, permanent wasserbenetzbare vulkanisate ergebende polysiloxanmasse.
NO900279L (no) Alkylerte polyetyleniminderivater og fremgangsmaate for fremstilling derav samt anvendelse av derivatene.
FI860945A0 (fi) ^-laktamantibiotika, foerfarande foer deras framstaellning och deras anvaendning som och i laekemedel.
ATE155138T1 (de) Unsymmetrische aryl-phosphite
DE68911208D1 (de) Selbstklebende, härtbare Organopolysiloxanzusammensetzung.
AR241082A1 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
DE69022094D1 (de) Bei Raumtemperartur härtbare Organopolysiloxanmassen.
FI870971A (fi) Nya reaktionsprodukter och deras anvaendning som katalysatorer vid framstaellning av isocyanatbaserade plaster.
FI98121B (fi) Varastoitaessa pysyvä, hammasplakkia estävä oraalinen koostumus
DK0431579T3 (da) Substituerede cyclohexener som midler med virkning på centralnervesystemet
FI960077A0 (fi) Uudet (1-fenyyli-1-heterosyklyyli) alkaanijohdannaiset ja niiden käyttö hermostoa suojaavina aineina
FI875432A (fi) Substituerade aminopropionsyraamider, foerfaranden foer deras framstaellning, dessa innehaollande aemnen och deras anvaendning samt vid framstaellningen bildade nya mellanprodukter.
DK49487A (da) 9-n-substituerede derivater af erythromycylamin til anvendelse imod infektioner med gram-positive bakterier
ES2123739T3 (es) Nuevos analogos del eburnano, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.
DE3779991D1 (de) Dioxopiperidin-derivate enthaltende anxiolytische zusammensetzungen.
NO893847L (no) Dobbel pose for bruk som utvendig lunge.
FI883288A0 (fi) Anordning foer behandling av i vaexthus pao galler vaexande plantor.
DE3761935D1 (de) Betaetigungsanordnung an schutzhelmen.
NO913502L (no) Kompositt for anvendelse som hoeyenergi-sprengstoff eller drivmiddel.

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed